{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:40:07Z","timestamp":1751884807526,"version":"3.41.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03145-3","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T09:02:29Z","timestamp":1751878949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing understanding of autoimmune diseases and lung cancer: trends, themes, and future directions"],"prefix":"10.1007","volume":"16","author":[{"given":"Hao-Han","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Chen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"3","key":"3145_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3145_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","volume":"16","author":"E Giat","year":"2017","unstructured":"Giat E, Ehrenfeld M, Shoenfeld Y. Cancer and autoimmune diseases. Autoimmun Rev. 2017;16(10):1049\u201357.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3145_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.semarthrit.2021.03.015","volume":"51","author":"X Wu","year":"2021","unstructured":"Wu X, Peng H, Wen Y, Cai X, Li C, Zhong R, Huang Y, Chen J, Huo Z, Wang R, et al. Rheumatoid arthritis and risk of lung cancer: meta-analysis and Mendelian randomization study. Semin Arthritis Rheum. 2021;51(3):565\u201375.","journal-title":"Semin Arthritis Rheum"},{"issue":"6167","key":"3145_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, Boin F, Fava A, Thoburn C, Kinde I, et al. Association of the autoimmune disease scleroderma with an Immunologic response to cancer. Science. 2014;343(6167):152\u20137.","journal-title":"Science"},{"issue":"6","key":"3145_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"5","key":"3145_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2016.01.017","volume":"15","author":"P Zaenker","year":"2016","unstructured":"Zaenker P, Gray ES, Ziman MR. Autoantibody production in cancer\u2013the humoral immune response toward autologous antigens in cancer patients. Autoimmun Rev. 2016;15(5):477\u201383.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"3145_CR7","first-page":"100375","volume":"3","author":"D Dedousis","year":"2022","unstructured":"Dedousis D, Vassiliou AN, Cao S, Yammani D, Kyasaram RK, Shanahan J, Keinath MC, Zhang AL, Hsu ML, Fu P, et al. Comparing survival in patients with lung cancer with and without a history of common autoimmune disease. JTO Clin Res Rep. 2022;3(9):100375.","journal-title":"JTO Clin Res Rep"},{"issue":"1","key":"3145_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","volume":"6","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Ch\u00e1vez A, Keegan N, Khamashta MA, Lambotte O, Mariette X, Prat A, Su\u00e1rez-Almazor ME. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6(1):38.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3145_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1248\/bpb.b23-00713","volume":"47","author":"Y Ihara","year":"2024","unstructured":"Ihara Y, Sawa K, Imai T, Nonomiya Y, Shimomura Y, Ishihara A, Shintani A. Immune checkpoint inhibitor is associated with improved survival in advanced Non-small cell lung Cancer occurring in patients with autoimmune disease. Biol Pharm Bull. 2024;47(2):454\u201361.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"3145_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-Related adverse events associated with immune checkpoint Blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"issue":"12","key":"3145_CR11","doi-asserted-by":"publisher","first-page":"e2029917","DOI":"10.1001\/jamanetworkopen.2020.29917","volume":"3","author":"S Jacob","year":"2020","unstructured":"Jacob S, Rahbari K, Tegtmeyer K, Zhao J, Tran S, Helenowski I, Zhang H, Walunas T, Varga J, Dematte J, et al. Lung Cancer survival in patients with autoimmune disease. JAMA Netw Open. 2020;3(12):e2029917.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"3145_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41584-018-0074-9","volume":"14","author":"LH Calabrese","year":"2018","unstructured":"Calabrese LH, Calabrese C, Cappelli LC. Rheumatic immune-related adverse events from cancer immunotherapy. Nat Rev Rheumatol. 2018;14(10):569\u201379.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3145_CR13","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/JS9.0000000000002095","volume":"111","author":"J Tian","year":"2025","unstructured":"Tian J, Dong YX, Wang L, Wu YM, Zhao ZY, Che GW. Mapping the evolution of 3D printing in cardio-thoracic diseases: a global bibliometric analysis. Int J Surg. 2025;111(1):1629\u201335.","journal-title":"Int J Surg"},{"issue":"1","key":"3145_CR14","doi-asserted-by":"publisher","first-page":"2488074","DOI":"10.1080\/21645515.2025.2488074","volume":"21","author":"CJ Zuo","year":"2025","unstructured":"Zuo CJ, Tian J. Advancing the Understanding of the role of apoptosis in lung cancer immunotherapy: global research trends, key themes, and emerging frontiers. Hum Vaccin Immunother. 2025;21(1):2488074.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"3145_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jrsm.1729","volume":"15","author":"M Gusenbauer","year":"2024","unstructured":"Gusenbauer M. Beyond Google scholar, scopus, and web of science: an evaluation of the backward and forward citation coverage of 59 databases\u2019 citation indices. Res Synth Methods. 2024;15(5):802\u201317.","journal-title":"Res Synth Methods"},{"issue":"1","key":"3145_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther. 2015;17(1):212.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"3145_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMc1801663","volume":"378","author":"HK Akturk","year":"2018","unstructured":"Akturk HK, Michels AW. Adverse events associated with immune checkpoint Blockade. N Engl J Med. 2018;378(12):1163\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"3145_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12880-021-00580-w","volume":"21","author":"A Al-Ibraheem","year":"2021","unstructured":"Al-Ibraheem A, Hirmas N, Fanti S, Paez D, Abuhijla F, Al-Rimawi D, Al-Rasheed U, Abdeljalil R, Hawari F, Alrabi K, et al. Impact of (18)F-FDG PET\/CT, CT and EBUS\/TBNA on preoperative mediastinal nodal staging of NSCLC. BMC Med Imaging. 2021;21(1):49.","journal-title":"BMC Med Imaging"},{"key":"3145_CR19","doi-asserted-by":"publisher","first-page":"1167975","DOI":"10.3389\/fimmu.2023.1167975","volume":"14","author":"Q Yin","year":"2023","unstructured":"Yin Q, Wu L, Han L, Zheng X, Tong R, Li L, Bai L, Bian Y. Immune-related adverse events of immune checkpoint inhibitors: a review. Front Immunol. 2023;14:1167975.","journal-title":"Front Immunol"},{"issue":"12","key":"3145_CR20","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/onco.13931","volume":"26","author":"R Pathak","year":"2021","unstructured":"Pathak R, Katel A, Massarelli E, Villaflor VM, Sun V, Salgia R. Immune checkpoint Inhibitor-Induced myocarditis with myositis\/myasthenia Gravis overlap syndrome: a systematic review of cases. Oncologist. 2021;26(12):1052\u201361.","journal-title":"Oncologist"},{"key":"3145_CR21","doi-asserted-by":"crossref","unstructured":"Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. Int J Mol Sci. 2019;20(3):593.","DOI":"10.3390\/ijms20030593"},{"issue":"12","key":"3145_CR22","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1164\/rccm.201907-1288LE","volume":"200","author":"CT Lee","year":"2019","unstructured":"Lee CT, Strek ME. Occupational burden in chronic respiratory disease: call for recognition, training, and data capture. Am J Respir Crit Care Med. 2019;200(12):1558\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3145_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/oncolo\/oyac226","volume":"28","author":"AJ Frank","year":"2023","unstructured":"Frank AJ, Dagogo-Jack I, Dobre IA, Tait S, Schumacher L, Fintelmann FJ, Fingerman LM, Keane FK, Montesi SB. Management of lung cancer in the patient with interstitial lung disease. Oncologist. 2023;28(1):12\u201322.","journal-title":"Oncologist"},{"key":"3145_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12885-016-2444-5","volume":"16","author":"JK Park","year":"2016","unstructured":"Park JK, Yang JA, Ahn EY, Chang SH, Song YW, Curtis JR, Lee EB. Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis. BMC Cancer. 2016;16:381.","journal-title":"BMC Cancer"},{"key":"3145_CR25","doi-asserted-by":"publisher","first-page":"977265","DOI":"10.3389\/fimmu.2022.977265","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Yan YD, Shi FH, Lin HW, Gu ZC, Li J. Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: a systematic review and meta-analysis. Front Immunol. 2022;13:977265.","journal-title":"Front Immunol"},{"issue":"1","key":"3145_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13075-018-1678-9","volume":"20","author":"ZE Betteridge","year":"2018","unstructured":"Betteridge ZE, Priest L, Cooper RG, McHugh NJ, Blackhall F, Lamb JA. Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer. Arthritis Res Ther. 2018;20(1):176.","journal-title":"Arthritis Res Ther"},{"key":"3145_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.lungcan.2017.07.026","volume":"111","author":"C Sculier","year":"2017","unstructured":"Sculier C, Bentea G, Ruelle L, Grigoriu B, Coureau M, Gorham J, Sideris S, Holbrechts S, Lafitte JJ, Meert AP, et al. Autoimmune paraneoplastic syndromes associated to lung cancer: a systematic review of the literature: part 5: neurological auto-antibodies, discussion, flow chart, conclusions. Lung Cancer. 2017;111:164\u201375.","journal-title":"Lung Cancer"},{"issue":"2","key":"3145_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00403-016-1704-1","volume":"309","author":"G Merlo","year":"2017","unstructured":"Merlo G, Clapasson A, Cozzani E, Sanna L, Pesce G, Bagnasco M, Burlando M, Parodi A. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets. Arch Dermatol Res. 2017;309(2):87\u201395.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"3145_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10637-020-00974-7","volume":"39","author":"M Osaki","year":"2021","unstructured":"Osaki M, Tachikawa R, Ohira J, Hara S, Tomii K. Anti-transcriptional intermediary factor 1-\u03b3 antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: a case report. Invest New Drugs. 2021;39(1):251\u20135.","journal-title":"Invest New Drugs"},{"key":"3145_CR30","first-page":"635","volume":"6","author":"D Khan","year":"2015","unstructured":"Khan D, Ansar Ahmed S. The immune system is a natural target for Estrogen action: opposing effects of Estrogen in two prototypical autoimmune diseases. Front Immunol. 2015;6:635.","journal-title":"Front Immunol"},{"issue":"20","key":"3145_CR31","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1111\/1759-7714.14939","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Wang H, Xue F, Jiang T, Chen N, Wang T, Zhang Y, Zhang G, Fu J, Wu Q. Frequency changes in HLA-I alleles: a marker to guide immunotherapy in lung adenocarcinoma patients and its relationship with tumor mutational burden and PD-L1 expression. Thorac Cancer. 2023;14(20):1932\u201340.","journal-title":"Thorac Cancer"},{"issue":"1","key":"3145_CR32","doi-asserted-by":"publisher","first-page":"2458948","DOI":"10.1080\/21645515.2025.2458948","volume":"21","author":"J Le","year":"2025","unstructured":"Le J, Sun Y, Deng G, Dian Y, Xie Y, Zeng F. Immune checkpoint inhibitors in cancer patients with autoimmune disease: safety and efficacy. Hum Vaccin Immunother. 2025;21(1):2458948.","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"3145_CR33","doi-asserted-by":"publisher","first-page":"e0306995","DOI":"10.1371\/journal.pone.0306995","volume":"19","author":"H Sumimoto","year":"2024","unstructured":"Sumimoto H, Noda S, Koide H, Douke Y, Sakai K, Nishikawa A, Tomioka A, Hori M, Nakato H, Kimura Y, et al. Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors. PLoS One. 2024;19(7):e0306995.","journal-title":"PLoS ONE"},{"key":"3145_CR34","doi-asserted-by":"publisher","first-page":"107894","DOI":"10.1016\/j.lungcan.2024.107894","volume":"194","author":"T Asao","year":"2024","unstructured":"Asao T, Shukuya T, Uemura K, Kitadai R, Yamamoto G, Mouri A, Tamaoka M, Imai R, Tsukita Y, Isobe K, et al. Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint Blockade therapy: survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047). Lung Cancer. 2024;194:107894.","journal-title":"Lung Cancer"},{"issue":"7","key":"3145_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cllc.2023.05.006","volume":"24","author":"WY Aung","year":"2023","unstructured":"Aung WY, Lee CS, Morales J, Rahman H, Seetharamu N. Safety and efficacy of immune checkpoint inhibitors in cancer patients and preexisting autoimmune disease: a systematic review and meta-analysis in non-small-cell lung cancer. Clin Lung Cancer. 2023;24(7):598\u2013612.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"3145_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jamaoncol.2018.5860","volume":"5","author":"Y Toi","year":"2019","unstructured":"Toi Y, Sugawara S, Sugisaka J, Ono H, Kawashima Y, Aiba T, Kawana S, Saito R, Aso M, Tsurumi K, et al. Profiling preexisting antibodies in patients treated with anti-PD-1 therapy for advanced non-small cell lung cancer. JAMA Oncol. 2019;5(3):376\u201383.","journal-title":"JAMA Oncol"},{"issue":"6","key":"3145_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","volume":"24","author":"J Choi","year":"2012","unstructured":"Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 2012;24(6):651\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"3145_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ags3.12757","volume":"8","author":"J Kawada","year":"2024","unstructured":"Kawada J, Saito T, Kurokawa Y, Kawabata R, Takeno A, Takeoka T, Nose Y, Wada H, Eguchi H, Doki Y. Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer. Ann Gastroenterol Surg. 2024;8(2):243\u201350.","journal-title":"Ann Gastroenterol Surg"},{"key":"3145_CR39","doi-asserted-by":"publisher","first-page":"102288","DOI":"10.1016\/j.canep.2022.102288","volume":"81","author":"HS Yoon","year":"2022","unstructured":"Yoon HS, Zheng W, Cai H, Wu J, Shidal C, Wang J, Shu XO, Waterboer T, Blot WJ, Cai Q. Pre-diagnostic circulating p53 autoantibodies and subsequent lung cancer risk in low-income African and European Americans. Cancer Epidemiol. 2022;81:102288.","journal-title":"Cancer Epidemiol"},{"key":"3145_CR40","doi-asserted-by":"crossref","unstructured":"Choueiki JM, Sales S, Callicott S, Ashman D, Worst K, Badillo A, Varda BK, Mayhew A, Xu TO, Levitt MA. Is collaborative care the future of medicine? Lessons learned from the care of children with colorectal conditions. Child (Basel). 2024;11(5):570.","DOI":"10.3390\/children11050570"},{"key":"3145_CR41","doi-asserted-by":"crossref","unstructured":"Wear D, Bhagirath E, Balachandar A, Vegh C, Pandey S. Autophagy inhibition via hydroxychloroquine or 3-methyladenine enhances chemotherapy-induced apoptosis in Neuro-Blastoma and glioblastoma. Int J Mol Sci 2023;24(15):12052.","DOI":"10.3390\/ijms241512052"},{"key":"3145_CR42","doi-asserted-by":"publisher","first-page":"8916464","DOI":"10.1155\/2022\/8916464","volume":"2022","author":"JE Yu","year":"2022","unstructured":"Yu JE, Kim Y, Hong DE, Lee DW, Chang JY, Yoo SS, Kim MJ, Son DJ, Yun J, Han SB, et al. Bee venom triggers autophagy-induced apoptosis in human lung cancer cells via the mTOR signaling pathway. J Oncol. 2022;2022:8916464.","journal-title":"J Oncol"},{"key":"3145_CR43","doi-asserted-by":"crossref","unstructured":"Choi EY, Han EJ, Jeon SJ, Lee SW, Moon JM, Jung SH, Jung JY. Piperlongumine induces apoptosis and cytoprotective autophagy via the MAPK signaling pathway in human oral cancer cells. Biomedicines. 2023;11(9):2442.","DOI":"10.3390\/biomedicines11092442"},{"key":"3145_CR44","doi-asserted-by":"crossref","unstructured":"Ruiz JI, Lei X, Giordano SH, Zhao H, Rajan SS, Lin H, Suarez-Almazor ME. Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study. Lancet Rheumatol. 2025;7(5):e333\u2013e342.","DOI":"10.1016\/S2665-9913(24)00379-5"},{"key":"3145_CR45","doi-asserted-by":"crossref","unstructured":"Qian Y, Mao M, Nian F. The effect of TNF-\u03b1 on CHD and the relationship between TNF-\u03b1 antagonist and CHD in rheumatoid arthritis: a systematic review. Cardiol Res Pract. 2022;2022:6192053.","DOI":"10.1155\/2022\/6192053"},{"issue":"11","key":"3145_CR46","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/cncr.30642","volume":"123","author":"DB Johnson","year":"2017","unstructured":"Johnson DB, Sullivan RJ, Menzies AM. Immune checkpoint inhibitors in challenging populations. Cancer. 2017;123(11):1904\u201311.","journal-title":"Cancer"},{"key":"3145_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.smim.2017.08.001","volume":"32","author":"J Chen","year":"2017","unstructured":"Chen J, Domingue JC, Sears CL. Microbiota dysbiosis in select human cancers: evidence of association and causality. Semin Immunol. 2017;32:25\u201334.","journal-title":"Semin Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03145-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03145-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03145-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:03:25Z","timestamp":1751882605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03145-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03145-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethical approval was needed because this is not a human study, but only online information was used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"None.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}],"article-number":"1275"}}